Back to User profile » Dr Dale Chappell
Paper published by Dr Dale Chappell:
Original Research
Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England
Kilcoyne A, Jordan E, Thomas K, Pepper AN, Zhou A, Chappell D, Amarapala M, Thériault RK, Thompson M
ClinicoEconomics and Outcomes Research 2022, 14:231-247
Published Date: 14 April 2022